Cost-effectiveness analysis of olaparib maintenance therapy for BRCA mutation ovarian cancer in the public sector in Malaysia.
Article in PLOS ONE (February 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Real-world Study on the Effect of PARPi as Maintenance Therapy on Platinum Sensitivity after First- and Second-line Chemotherapy in Patients with Recurrent High-grade Serous Epithelial Ovarian Cancer
Article in Current Cancer Drug Targets (January 2024)
Cost-effectiveness analysis of niraparib maintenance therapy in Chinese patients with platinum-sensitive recurrent ovarian cancer
Article in Gynecologic Oncology (May 2023)